Filing Details
- Accession Number:
- 0001127602-17-001310
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-06 18:59:51
- Reporting Period:
- 2017-01-04
- Filing Date:
- 2017-01-06
- Accepted Time:
- 2017-01-06 18:59:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236397 | Daniel Bradbury | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Transaction Summary
| Sold: | 600 shares | Avg. Price: $135.01 | Total Value: $81,008.20 |
| Number of Shares After Transactions: | 16,465 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-04 | 600 | $71.09 | 17,065 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-04 | 200 | $133.93 | 16,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-04 | 400 | $135.56 | 16,465 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-01-04 | 600 | $0.00 | 600 | $71.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,000 | 2014-05-29 | 2023-05-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 200 shares sold ranging from $133.47 to $134.38 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 400 shares sold ranging from $135.31 to $135.98 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
